• Emil Pot, Co-Founder and CEO of Allero Therapeutics

  • Oct 20 2021
  • Duración: 49 m
  • Podcast

Emil Pot, Co-Founder and CEO of Allero Therapeutics

  • Resumen

  • As something that affects as much as 10% of the global population, food allergies are an important topic of discussion in this value-packed episode of High Potential Start-ups.

    In episode 3, guest speaker Emil Pot, Co-Founder and CEO of Allero Therapeutics, and host Nick Ross, Co-Founder of Cavenagh Health, delve into numerous talking points surrounding everything from food-related immune disorders to running a successful biotech company. 

    Emil’s career started in law, but his keen interest in science quickly led to biotech becoming the central point of his career.

    Now, Emil and his team at Allero Therapeutics have developed an innovative solution to treating autoimmune disorders like celiac disease.

    Get in touch with Emil.

    Get in Touch with Nick.

    Más Menos
activate_WEBCRO358_DT_T2

Lo que los oyentes dicen sobre Emil Pot, Co-Founder and CEO of Allero Therapeutics

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.